New beginners course Zhineng Qigong for people with Parkinson’s

Zhineng Qigong consists of easy-to-learn movements that bring body and mind into balance in a natural way. This technique promotes the free flow of Qi in the body and helps to initiate healing processes in a natural way, improves health, strengthens the immune system,
reduces sensitivity to stress and improves memory and cognitive abilities.

Advances in the use of focused ultrasound to treat Parkinson’s disease

In recent years, researchers have made significant progress in using focused ultrasound to treat Parkinson's disease. This noninvasive technique offers a promising alternative to conventional treatments and may be particularly beneficial for patients who are not candidates for or do not want deep brain stimulation (DBS).

Non-invasive brain stimulation (NIBS) and the EU Medical Device Regulation (MDR)

For some time now, the Parkinson Association has been participating in the EU project REMOPD, which aims to develop non-invasive DBS technologies. This project integrates various international approaches to neurostimulation, including electromagnetic (EM) interference and ultrasound (US).

Annovis Bio: New findings on Parkinson's treatment with Buntanetap

On July 2, 2024, Annovis Bio, a drug platform company based in Malvern, Pennsylvania, released promising results from its Phase III study for the treatment of Parkinson's disease with the drug Buntanetap. These new data show significant improvements in the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and patients' cognitive abilities.

Current research results on the connection between fine dust and Parkinson's

Recent studies from England and the USA suggest that particulate matter and air pollutants such as NO2 may increase the risk of neurodegenerative diseases, particularly Parkinson's. These studies have shown significant differences in disease rates between areas with high levels of particulate matter and those with lots of green space. This report summarises the main findings and their implications, while also taking into account the limitations of the studies.

Looking over the fence – contributions from around the world

In a remarkable medical research project, Phase 2 trials are showing promising results for patients with multiple sclerosis (MS) and Parkinson's disease. Researchers at UT Southwestern Medical Center have found that a daily intake of gold nanocrystals can significantly reverse disease-related energy deficits in the brain and lead to functional improvements in patients. This innovative method could potentially offer new hope for people with these serious neurodegenerative diseases.

Strategies in the fight against Parkinson's psychosis

Parkinson's disease, often only associated with the typical motor symptoms such as tremors and lack of movement, reveals a far more complex and stressful facet upon closer inspection. Psychotic symptoms, such as delusions and visual hallucinations, often occur in Parkinson's patients and represent an immense burden for those affected and their relatives. While acoustic hallucinations dominate in schizophrenia, in Parkinson's it is usually visual hallucinations that frighten the patients .
App and nurses accompany you in everyday life
ParkinsonGo TM combines precise gait analysis and a smartphone app with intensive support from Parkinson Telenurses. The aim is to slow down the progression of the disease, maintain mobility and independence and thereby improve the quality of life of those affected. Using sensors attached to the shoes, the ParkinsonGo app analyzes gait quality and records symptom patterns (e.g. poor mobility) as well as everyday challenges in a diary. Intelligent algorithms derive personalized recommendations for action in the form of physiotherapeutic exercise plans and tips for dealing with the disease.

Propionate Supplements and Parkinson's: New Research

In order to improve mobility and safety in everyday life, the medical technology company Portabiles HealthCare Technologies has developed the hybrid care model ParkinsonGo TM together with neurologists and patients. ParkinsonGo TM has been successfully tested and has been reimbursed by several health insurance companies in Germany since January 2024.

App and nurses accompany you in everyday life
ParkinsonGo TM combines precise gait analysis and a smartphone app with intensive support from Parkinson Telenurses. The aim is to slow down the progression of the disease, maintain mobility and independence and thereby improve the quality of life of those affected. Using sensors attached to the shoes, the ParkinsonGo app analyzes gait quality and records symptom patterns (e.g. poor mobility) as well as everyday challenges in a diary. Intelligent algorithms derive personalized recommendations for action in the form of physiotherapeutic exercise plans and tips for dealing with the disease.

Can prasinezumab slow the progression of motor symptoms?

An article originally published in the Ärzteblatt is about the effect of the drug prasinezumab on motor symptoms. In a clinical trial, it was observed that the placebo group experienced a major worsening of their symptoms by 12,29 points. In the group treated with prasinezumab, this deterioration was significantly reduced - to just 4,39 points